The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Gut Microbiome and Hepatocellular Carcinoma: Implications for Early Diagnostic Biomarkers and Novel Therapies
Authors
Keywords
-
Journal
Liver Cancer
Volume -, Issue -, Pages -
Publisher
S. Karger AG
Online
2021-12-22
DOI
10.1159/000521358
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Faecal microbiota transplantation enhances efficacy of immune checkpoint inhibitors therapy against cancer
- (2021) Yong-Bo Kang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Relationship between intestinal microbial dysbiosis and primary liver cancer
- (2019) Lei Zhang et al. Hepatobiliary & Pancreatic Diseases International
- Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma
- (2019) Johanna DiStefano et al. Cancers
- Antimicrobial Peptides: Potential Application in Liver Cancer
- (2019) Chunye Zhang et al. Frontiers in Microbiology
- Altered Gut Microbiota in HIV Infection: Future Perspective of Fecal Microbiota Transplantation Therapy
- (2018) Yongbo Kang et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- Change in gut microbiota for eczema: Implications for novel therapeutic strategies
- (2018) Y. Kang et al. ALLERGOLOGIA ET IMMUNOPATHOLOGIA
- Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies
- (2018) Yongbo Kang et al. Clinics and Research in Hepatology and Gastroenterology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
- (2018) Hmwe Hmwe Kyu et al. LANCET
- Gut Microbiota’s Relationship with Liver Disease and Role in Hepatoprotection by Dietary Natural Products and Probiotics
- (2018) Xiao Meng et al. Nutrients
- Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
- (2017) Daniela Sia et al. GASTROENTEROLOGY
- Gut microbiota and obesity: implications for fecal microbiota transplantation therapy
- (2017) Hormones-International Journal of Endocrinology and Metabolism
- Gut microbiota and hepatitis-B-virus-induced chronic liver disease: implications for faecal microbiota transplantation therapy
- (2017) Y. Kang et al. JOURNAL OF HOSPITAL INFECTION
- The gut microbiome and liver cancer: mechanisms and clinical translation
- (2017) Le-Xing Yu et al. Nature Reviews Gastroenterology & Hepatology
- Gut microbiota and colorectal cancer: insights into pathogenesis for novel therapeutic strategies
- (2017) Yongbo Kang et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Can intestinal microbiota be associated with non-intestinal cancers?
- (2017) Camille Jacqueline et al. Scientific Reports
- Randomized-controlled trial of rifaximin versus norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis
- (2016) Asem Elfert et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Signals from the gut microbiota to distant organs in physiology and disease
- (2016) Bjoern O Schroeder et al. NATURE MEDICINE
- Tumor Markers for Hepatocellular Carcinoma: Simple and Significant Predictors of Outcome in Patients with HCC
- (2015) Hidenori Toyoda et al. Liver Cancer
- A Randomized, Double-Blind, Controlled Trial Comparing Rifaximin Plus Lactulose With Lactulose Alone in Treatment of Overt Hepatic Encephalopathy
- (2013) Barjesh Chander Sharma et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Therapeutic Potential of Fecal Microbiota Transplantation
- (2013) Loek P. Smits et al. GASTROENTEROLOGY
- Epidemiology of Hepatocellular Carcinoma
- (2013) Sahil Mittal et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis
- (2012) Jiannis Vlachogiannakos et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Functional interactions between the gut microbiota and host metabolism
- (2012) Valentina Tremaroli et al. NATURE
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Review article: the management of hepatocellular carcinoma
- (2009) R. CABRERA et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Cell surface-bound IL-1 is an upstream regulator of the senescence-associated IL-6/IL-8 cytokine network
- (2009) A. V. Orjalo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Probiotics and gastrointestinal disease: successes, problems and future prospects
- (2009) Eamonn P Culligan et al. Gut Pathogens
- Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
- (2008) Scott L. Friedman PHYSIOLOGICAL REVIEWS
- Role of probiotics, prebiotics and synbiotics in chemoprevention for colorectal cancer
- (2008) Constantine Iosif Fotiadis et al. WORLD JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started